Sana Biotechnology Valuation Multiples

Sana Biotechnology Overview

About Sana Biotechnology

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Founded

2018

HQ

Employees

194

Website

sana.com

Sectors

BiopharmaceuticalsBioTech

Financials (LTM)

Revenue: —

EBITDA: ($182M)

EV

$1B

Valuation Multiples

Multiples.vc

Start free trial

Sana Biotechnology Financials

Sana Biotechnology reported last 12-month revenue of — and negative EBITDA of ($182M).

In the same LTM period, Sana Biotechnology generated — in gross profit, ($182M) in EBITDA losses, and had net loss of ($231M).

Sana Biotechnology P&L

In the most recent fiscal year, Sana Biotechnology reported revenue of — and EBITDA of ($183M).

Sana Biotechnology expects next 12-month revenue of XXX and NTM EBITDA of XXX

Sana Biotechnology Stock Performance

Sana Biotechnology has current market cap of $1B, and enterprise value of $1B.

Sana Biotechnology's stock price is $4.21.

Sana Biotechnology Valuation Multiples

Sana Biotechnology trades at (5.8x) EV/EBITDA.

Sana Biotechnology Financial Valuation Multiples

As of March 21, 2026, Sana Biotechnology has market cap of $1B and EV of $1B.

Equity research analysts estimate Sana Biotechnology's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Sana Biotechnology has a P/E ratio of (4.9x).

Sana Biotechnology Margins & Growth Rates

Sana Biotechnology's revenue in the last fiscal year grew by —.

Sana Biotechnology's revenue per employee in the last FY averaged $0.0M.

Sana Biotechnology Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Sana Biotechnology M&A Activity

Sana Biotechnology acquired XXX companies to date.

Last acquisition by Sana Biotechnology was on XXXXXXXX, XXXXX. Sana Biotechnology acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Sana Biotechnology Investment Activity

Sana Biotechnology invested in XXX companies to date.

Sana Biotechnology made its latest investment on XXXXXXXX, XXXXX. Sana Biotechnology invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).